Deutsche Bank Ag\ Kiniksa Pharmaceuticals, Ltd. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $6,787 - $8,369	385 Added 0.42%	91,744 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $5,273 - $6,998	-367 Reduced 0.4%	91,359 $1.6 Million
Q3 2023 Nov 09, 2023	BUY	$13.62 - $20.2 $30,236 - $44,844	2,220 Added 2.48%	91,726 $1.59 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $94,680 - $149,457	-9,069 Reduced 9.2%	89,506 $1.26 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $249,481 - $368,159	23,316 Added 30.98%	98,575 $1.06 Million
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $12,025 - $17,953	-1,053 Reduced 1.38%	75,259 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $819 - $1,126	84 Added 0.11%	76,312 $980,000
Q2 2022 Aug 11, 2022	SELL	$7.6 - $11.41 $10,868 - $16,316	-1,430 Reduced 1.84%	76,228 $739,000
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $25,193 - $33,510	-2,709 Reduced 3.37%	77,658 $772,000
Q4 2021 Feb 11, 2022	BUY	$10.39 - $15.15 $13,039 - $19,013	1,255 Added 1.59%	80,367 $946,000
Q3 2021 Nov 04, 2021	SELL	$11.39 - $16.23 $6,184 - $8,812	-543 Reduced 0.68%	79,112 $901,000
Q2 2021 Aug 11, 2021	SELL	$13.22 - $19.09 $475,655 - $686,858	-35,980 Reduced 31.12%	79,655 $1.11 Million
Q1 2021 May 13, 2021	BUY	$16.68 - $23.97 $1.52 Million - $2.18 Million	90,931 Added 368.08%	115,635 $2.14 Million
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $139,889 - $199,909	9,452 Added 61.97%	24,704 $436,000
Q3 2020 Nov 12, 2020	BUY	$15.21 - $25.53 $78,118 - $131,122	5,136 Added 50.77%	15,252 $233,000
Q2 2020 Aug 13, 2020	BUY	$15.08 - $26.0 $81,809 - $141,050	5,425 Added 115.65%	10,116 $257,000
Q1 2020 May 14, 2020	SELL	$11.0 - $19.76 $3,102 - $5,572	-282 Reduced 5.67%	4,691 $72,000
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $5,874 - $14,528	1,121 Added 29.1%	4,973 $54,000
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $46,512 - $90,627	-5,707 Reduced 59.7%	3,852 $31,000
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.39 $55,506 - $85,739	-4,205 Reduced 30.55%	9,559 $127,000
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $108,053 - $180,359	6,783 Added 97.16%	13,764 $246,000
Q4 2018 Feb 14, 2019	SELL	$16.25 - $28.09 $125,385 - $216,742	-7,716 Reduced 52.5%	6,981 $195,000
Q3 2018 Dec 21, 2021	BUY	$13.23 - $30.93 $22,636 - $52,921	1,711 Added 13.18%	14,697 $374,000
Q3 2018 Nov 14, 2018	BUY	$13.23 - $30.93 $171,804 - $401,656	12,986 New	12,986 $330,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account